Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Optimizing PCR assays for DNA-based cancer diagnostics.

Bashir A, Lu Q, Carson D, Raphael BJ, Liu YT, Bafna V.

J Comput Biol. 2010 Mar;17(3):369-81. doi: 10.1089/cmb.2009.0203.

2.

Optimization of primer design for the detection of variable genomic lesions in cancer.

Bashir A, Liu YT, Raphael BJ, Carson D, Bafna V.

Bioinformatics. 2007 Nov 1;23(21):2807-15. Epub 2007 Aug 30.

PMID:
17766270
3.

Amplification and thrifty single-molecule sequencing of recurrent somatic structural variations.

Patel A, Schwab R, Liu YT, Bafna V.

Genome Res. 2014 Feb;24(2):318-28. doi: 10.1101/gr.161497.113. Epub 2013 Dec 4.

4.
5.

Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction.

Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ.

Blood. 1997 Sep 15;90(6):2456-64.

6.

Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.

Vaandrager JW, Schuuring E, Raap T, Philippo K, Kleiverda K, Kluin P.

Genes Chromosomes Cancer. 2000 Jan;27(1):85-94.

PMID:
10564590
7.

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.

Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.

Blood. 1996 Sep 1;88(5):1771-9.

8.

bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis.

Chibbar R, Leung K, McCormick S, Ritzkalla K, Strickler J, Staggs R, Poppema S, Brunning RD, McGlennen RC.

Mod Pathol. 1998 Nov;11(11):1089-97.

PMID:
9831207
9.

Utilization of polymerase chain reaction technology in the detection of solid tumors.

Raj GV, Moreno JG, Gomella LG.

Cancer. 1998 Apr 15;82(8):1419-42. Review.

PMID:
9554517
10.

Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.

Suzuki H, Zhou X, Yin J, Lei J, Jiang HY, Suzuki Y, Chan T, Hannon GJ, Mergner WJ, Abraham JM, et al.

Hum Mol Genet. 1995 Oct;4(10):1883-7.

PMID:
8595411
11.

Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.

Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.

Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):409-15.

PMID:
16618910
12.

DNA array-based method for detection of large rearrangements in the BRCA1 gene.

Frolov A, Prowse AH, Vanderveer L, Bove B, Wu H, Godwin AK.

Genes Chromosomes Cancer. 2002 Nov;35(3):232-41.

PMID:
12353265
13.

Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.

Ko JY, Lee TC, Hsiao CF, Lin GL, Yen SH, Chen KY, Hsiung CA, Chen PJ, Hsu MM, Jou YS.

Cancer. 2002 Apr 1;94(7):1987-96.

14.

Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.

Raschke S, Balz V, Efferth T, Schulz WA, Florl AR.

Genes Chromosomes Cancer. 2005 Jan;42(1):58-67.

PMID:
15495191
15.
16.

Alu-polymerase chain reaction genomic fingerprinting technique identifies multiple genetic loci associated with pancreatic tumourigenesis.

McKie AB, Iwamura T, Leung HY, Hollingsworth MA, Lemoine NR.

Genes Chromosomes Cancer. 1997 Jan;18(1):30-41.

PMID:
8993978
17.

Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples.

Mizuarai S, Machida T, Kobayashi T, Komatani H, Itadani H, Kotani H.

Mol Cancer. 2011 Mar 29;10:31. doi: 10.1186/1476-4598-10-31.

18.
19.
20.

Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.

Sarris AH, Luthra R, Cabanillas F, Morris SW, Pugh WC.

Leuk Lymphoma. 1998 May;29(5-6):507-14.

PMID:
9643564

Supplemental Content

Support Center